Article

Company withdraws application for stress incontinence drug

Eli Lilly said it has withdrawn its new drug application for duloxetine hydrochloride for the treatment of stress urinary incontinence.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

© 2025 MJH Life Sciences

All rights reserved.